Myristyl nicotinate (CAS No 273203-62-6) is a compound researched primarily in the field of dermatology due to its unique properties as an ester of nicotinic acid It is known to enhance skin appearance and function by increasing blood flow to the skin surface The mechanism of action involves the modulation of nicotinic acid receptors which play a role in cellular lipid metabolism and vasodilation In vitro studies often observe activity within the nanomolar to low micromolar range suggesting potent efficacy at small concentrations Typical applications include the use of various skin cell models and animal studies for evaluating its effects on skin health and potential use in cosmetic formulations It is also explored in drug screening for its potential therapeutic benefits Experimental concentrations typically depend on the specific research design allowing for adaptability in various investigative environments